BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $4.613B (100.0% shares, 0.0% debt)

Holdings (5)

— CEREVEL THERAPEUTICS HLDNG I 41.5%

Value $1.912B Shares 60,632,356 Share Price $31.54 Est. Cost/Share — Unrealized @ Report Date —

SGRY SURGERY PARTNERS INC 35.2%

Value $1.623B Shares 58,248,249 Share Price $27.86 Est. Cost/Share — Unrealized @ Report Date —

— DIVERSEY HLDGS LTD 21.8%

Value $1.008B Shares 236,561,159 Share Price $4.26 Est. Cost/Share — Unrealized @ Report Date —

AVAH AVEANNA HEALTHCARE HLDGS INC 1.4%

Value $63.65M Shares 81,600,880 Share Price $0.78 Est. Cost/Share — Unrealized @ Report Date —

ADV ADVANTAGE SOLUTIONS INC 0.1%

Value $6.011M Shares 2,890,000 Share Price $2.08 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	CEREVEL THERAPEUTICS HLDNG I	60,632,356	$1.912B	41.5%	$31.54	—	—	COM	15678U128
SGRY	SURGERY PARTNERS INC	58,248,249	$1.623B	35.2%	$27.86	—	—	COM	86881A100
—	DIVERSEY HLDGS LTD	236,561,159	$1.008B	21.8%	$4.26	—	—	ORD SHS	G28923103
AVAH	AVEANNA HEALTHCARE HLDGS INC	81,600,880	$63.65M	1.4%	$0.78	—	—	COM	05356F105
ADV	ADVANTAGE SOLUTIONS INC	2,890,000	$6.011M	0.1%	$2.08	—	—	COM CL A	00791N102